BU-NOT-SET

CONTACT US
For lyophilisation, excipients really do matter
  • Drug product
Eyes
Insight
The challenges of serialisation
  • Manufacturing
Eyes
Insight
The oncolytic efficacy and in vivo pharmacokinetics of [2-(4- Chlorophenyl)quinolin-4-yl](piperidine-2-yl)methanol (Vacquinol-1) are governed by distinct stereochemical features
  • Drug substance
Eyes
Insight
Strategies to prepare for serialisation
  • Manufacturing
Eyes
Insight
A Versatile One-Pot Procedure for the Synthesis of 5-Aryl-6H- 1,3,4-thiadiazine-2-amines from Aromatic Ketones
  • Drug substance
Eyes
Insight
Insight
  • Biologics
Unlocking the potential of RNA therapeutics through innovation and collaboration
White paper
  • Analytical chemistry
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
Insight
  • Biologics
Enhancing the production of RNA with continuous manufacturing
Fact sheet
  • Drug product
GERTEIS MINI-PACTOR® Advanced dry granulation services
Case study
  • Biologics
Overcoming oncolytic virus therapy production challenges through collaboration
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach